Top Markets
Coin of the day
Hyloris Pharmaceuticals S.A. Hyloris Pharmaceuticals S.A.

Hyloris Pharmaceuticals S.A.

HYL
Clasificación en acciones #19936
Hyloris Pharmaceuticals SA is dedicated to developing, manufacturing, and... Hyloris Pharmaceuticals SA is dedicated to developing, manufacturing, and bringing to market pharmaceutical products designed to fulfill critical unmet medical needs. The company's focus areas include cardiovascular health, oncology, women's health, and other significant therapeutic domains. Its cardiovascular portfolio features treatments for conditions such as atrial fibrillation, acute coronary syndrome, advanced and congestive heart failure, and coronary heart disease. Beyond this, Hyloris addresses a diverse range of other ailments, including post-operative pain management, dental indications, severe and recurring vulvovaginal candidiasis, specific cancers (like acute myeloid leukemia and small cell lung cancer), interstitial cystitis/painful bladder syndrome (IC/PBS), attention deficit hyperactivity disorder (ADHD), and various viral infections. Established in 2012, Hyloris Pharmaceuticals SA is headquartered in Liège, Belgium.
Precio por acción
$5.22
Última sincronización: 2026-08-25
Capitalización bursátil
$146.14M
Cambio (1 día)
-1.35%
Cambio (1 año)
-32.08%
País
BE
Comercio Hyloris Pharmaceuticals S.A. (HYL)

Categoría

Historial de desdoblamientos de acciones de Hyloris Pharmaceuticals S.A. (HYL)
La acción Hyloris Pharmaceuticals S.A. (símbolo: HYL) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 26, 2026.
Una acción HYL comprada antes de Aug 26, 2026 equivaldría hoy a 0 acciones HYL.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH